Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Icu Medical (ICUI) Interest Expenses (2016 - 2025)

Icu Medical's Interest Expenses history spans 10 years, with the latest figure at $19.8 million for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 19.75% year-over-year to $19.8 million, compared with a TTM value of $62.4 million through Dec 2025, down 13.7%, and an annual FY2021 reading of $858000.0, down 51.06% over the prior year.
  • Interest Expenses for Q3 2025 was $19.8 million at Icu Medical, down from $20.5 million in the prior quarter.
  • The five-year high for Interest Expenses was $24.7 million in Q3 2024, with the low at $161000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $15.8 million, with a median of $20.2 million recorded in 2025.
  • Year-over-year, Interest Expenses plummeted 78.86% in 2021 and then skyrocketed 10500.0% in 2022.
  • Tracing ICUI's Interest Expenses over 5 years: stood at $366000.0 in 2021, then soared by 4765.57% to $17.8 million in 2022, then skyrocketed by 35.75% to $24.2 million in 2023, then grew by 2.1% to $24.7 million in 2024, then decreased by 19.75% to $19.8 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Interest Expenses are $19.8 million (Q3 2025), $20.5 million (Q2 2025), and $22.0 million (Q1 2025).